AZN - Gracell Biotechnologies receives shareholder approval for merger with AstraZeneca
2024-02-20 08:09:53 ET
More on Gracell Biotechnologies
- With Its Sale To AstraZeneca, Gracell Blazes Exit Trail For Cash-Challenged Chinese Biotechs
- Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win
- AstraZeneca to buy Gracell Biotechnologies for $1.2 billion
- Gracell gains as FDA clears another study for lead asset
- Seeking Alpha’s Quant Rating on Gracell Biotechnologies